Skip to main content

Volume 18 Supplement 2

Rethinking the pros and cons of randomiszed controlled trials and observational studies in the era of big data and advanced methods: A panel discussion


Publication of this supplement has been supported by funding from a Canadian Institutes of Health Research Grant

Virtual24th February 2022

Meeting recording

Editor: Simon Décary, Université de Sherbrooke

  1. Randomized controlled trials (RCTs) have traditionally been considered the gold standard for medical evidence. However, in light of emerging methodologies in data science, many experts question the role of RCT...

    Authors: Pamela Fernainy, Alan A. Cohen, Eleanor Murray, Elena Losina, Francois Lamontagne and Nadia Sourial
    Citation: BMC Proceedings 2024 18(Suppl 2):1

Annual Journal Metrics

  • 2022 Citation Impact
    0.914 - SNIP (Source Normalized Impact per Paper)
    0.506 - SJR (SCImago Journal Rank)

    2023 Usage 
    196 Altmetric mentions